Does Memo Volt work? What the research actually shows
We took all ten ingredients back to their published human research and compared the studied dose with what a proprietary blend of this size can plausibly contain. This is the result, without rounding in anyone's favour.
Unknown, and unknowable from the label. One ingredient out of ten has genuine human memory evidence. Five have none. The formula itself has never been tested, and the proprietary blend prevents anyone checking whether the one good ingredient is present at a working dose.
That is not the same as saying it does nothing. It means the product asks you to take its central claim on trust, and the 60-day refund window is the only thing standing behind that trust.
The arithmetic problem
Add the studied doses of just three ingredients — saffron at 30mg, Morosil at 400mg and berberine at a conservative 900mg — and you are at 1,330mg before touching the other seven. Cinnamon's own research uses grams. A once-daily capsule serving cannot hold that. Something on this label is present at a fraction of its research dose, and because the blend is proprietary, the label will not tell you which.
This is the single most important fact on the page, and it applies to almost every proprietary-blend supplement rather than to Memo Volt uniquely. It is why we grade the product as unproven rather than as fraudulent: the ingredients are real and the doses are simply unknown.
What is missing
- No trial of the finished product. Not a small one, not a pilot, not an open-label observational study.
- No disclosed per-ingredient amounts. A single blend total, which is legal and unhelpful.
- No published third-party assay confirming label accuracy or purity.
- No named formulator or scientific advisory board with checkable credentials.
- No manufacturing facility disclosure beyond generic language.
None of those absences is unusual for a direct-response supplement. All of them would be present for a product with something to show, and their absence is information.
How it compares to what does have evidence
| Intervention | Evidence for memory in adults | Cost |
|---|---|---|
| Aerobic exercise, 150 min/week | Strong, repeated | Free |
| Treating high blood pressure | Strong | Covered care |
| Correcting hearing loss | Strong and underused | Covered care |
| Seven or more hours of sleep | Strong | Free |
| Saffron extract at trial dose | Modest, promising | Low |
| Memo Volt as a formula | Untested | $49–$69/bottle |
We include that comparison because it is the context the sales page omits. If you do all four of the free interventions and still want to add a supplement, that is a defensible decision. Buying the supplement while skipping the four is not.
Sources
- National Institute on Aging — can supplements prevent Alzheimer's disease?
- NCCIH — using dietary supplements wisely
- NIH Office of Dietary Supplements — ingredient fact sheets
- MedlinePlus — herb and supplement monographs
Keep reading
Ingredient by ingredient
Studied human dose against the quality of the cognitive evidence, for all ten. Where a dose is marked not established, no human trial has set one for any cognitive outcome.
| Ingredient | Studied dose | Evidence | What the research shows |
|---|---|---|---|
| Saffron Extract | 28–30mg/day | Multiple human RCTs | The strongest entry on the label by a distance. Randomised trials in adults with mild age-related memory complaints ran 16–22 weeks and reported modest gains on standardised cognitive scales, alongside a separate and larger body of research in low mood. |
| Morosil | 400mg/day | Human trials, wrong outcome | Real trials exist at a precise dose, but they measured body composition and waist circumference, not memory. Its presence here is metabolic, and 400mg is a large share of any blend. |
| Berberine HCl | 900–1500mg/day | Strong data, not cognitive | Well studied for glucose and lipids at doses far larger than a blend of this size could hold. The cognitive link is indirect and slow, and this is also the ingredient behind most digestive complaints and the diabetes interaction. |
| Corosolic Acid | 10–48mg/day | Small human trials | Modest post-meal glucose effects in short human studies. No cognitive outcomes measured. Adds to the same hypoglycaemia risk as berberine. |
| Ceylon Cinnamon Bark | 1–6g/day | Mixed human data | Blood-sugar effects are inconsistent across trials and the studied amounts are grams, not milligrams. Ceylon rather than cassia is a genuinely sensible choice on coumarin safety grounds. |
| Oleuropein | Varies widely | Cardiovascular data | Olive-leaf polyphenol with reasonable evidence for blood pressure and inflammation. Cognitive evidence is preclinical. Contributes to the blood-pressure interaction. |
| Fucoxanthin | Not established | Animal only | Metabolic and antioxidant effects in rodents. Human cognitive research is essentially absent, and absorption from a capsule is poorly characterised. |
| Fucoidan | Not established | Animal and in vitro | A large sulfated polysaccharide with poor oral bioavailability. Immune and antioxidant activity in the lab. Its most relevant human property is anticoagulant activity, which is a risk rather than a benefit. |
| Kudzu Flower Extract | Not established | Wrong plant part | Nearly all human kudzu research used the root, not the flower. Extrapolating from one to the other is not sound, and no cognitive outcome has been measured for either. |
| Xylitol | n/a | Not an active | A sugar alcohol used as sweetener and carrier. Contributes nothing cognitive and something to the digestive complaints. |